NSMAP: a method for spliced isoforms identification and quantification from RNA-Seq

• Published in: BMC bioinformatics 2011-05, Vol.12 (1), p.162-162, Article 162
• Main Authors: Xia, Zheng, Wen, Jianguo, Chang, Chung-Che, Zhou, Xiaobo
• Format: Article
• Language: English
• Subjects: Alternative Splicing; Base Sequence; DNA sequencing; Gene expression; Gene Expression Profiling - methods; Genetic algorithms; Humans; Messenger RNA; Methodology; Methods; Models, Genetic; Nucleotide sequencing; Oligonucleotide Probes - metabolism; Physiological aspects; Protein Isoforms - chemistry; Protein Isoforms - genetics; Protein Isoforms - isolation & purification; Protein Isoforms - metabolism; RNA Splicing; RNA, Messenger - genetics; Sequence Analysis, RNA - methods; Software
• ISSN: 1471-2105; 1471-2105
• DOI: 10.1186/1471-2105-12-162

The development of techniques for sequencing the messenger RNA (RNA-Seq) enables it to study the biological mechanisms such as alternative splicing and gene expression regulation more deeply and accurately. Most existing methods employ RNA-Seq to quantify the expression levels of already annotated isoforms from the reference genome. However, the current reference genome is very incomplete due to the complexity of the transcriptome which hiders the comprehensive investigation of transcriptome using RNA-Seq. Novel study on isoform inference and estimation purely from RNA-Seq without annotation information is desirable. A Nonnegativity and Sparsity constrained Maximum APosteriori (NSMAP) model has been proposed to estimate the expression levels of isoforms from RNA-Seq data without the annotation information. In contrast to previous methods, NSMAP performs identification of the structures of expressed isoforms and estimation of the expression levels of those expressed isoforms simultaneously, which enables better identification of isoforms. In the simulations parameterized by two real RNA-Seq data sets, more than 77% expressed isoforms are correctly identified and quantified. Then, we apply NSMAP on two RNA-Seq data sets of myelodysplastic syndromes (MDS) samples and one normal sample in order to identify differentially expressed known and novel isoforms in MDS disease. NSMAP provides a good strategy to identify and quantify novel isoforms without the knowledge of annotated reference genome which can further realize the potential of RNA-Seq technique in transcriptome analysis. NSMAP package is freely available at https://sites.google.com/site/nsmapforrnaseq.